(R,S)-Ketamine Promotes Striatal Neurogenesis and Sensorimotor Recovery Through Improving Poststroke Depression–Mediated Decrease in Atrial Natriuretic Peptide
Yujing Zhang, Bing Xie, Yin Yuan, Ting Zhou, Ping-Xi Xiao, Yuming Wu, You Shang, Shi-ying Yuan, Jian-Cheng Zhang
Biological Psychiatry Global Open Science April 1, 2021 DOI: 10.1016/j.bpsgos.2021.04.002 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Preclinical animal study Peer reviewed |
|---|---|
| Population | Mice subjected to transient middle cerebral artery occlusion, housed isolated or pair-housed with ovariectomized female mice; primary ependymal epithelial cells and choroid plexus epithelial cells cultured in vitro |
| Interventions | (R S)-ketamine Recombinant human atrial natriuretic peptide (ANP) protein |
| Duration | 2 weeks of (R,S)-ketamine treatment starting at 14 days postischemia; isolation starting at 3 days postischemia |
| Topics | Depression Esketamine Ketamine Neuroplasticity |
| Key points | (R,S)-ketamine alleviated poststroke social isolation-mediated depressive-like behaviors and promoted striatal neurogenesis and sensorimotor recovery via ANP in mice. The depression-like phenotype was negatively correlated with ANP levels in the atrium and plasma, and atrial GLP-1/GLP-1 receptor signaling was essential to ketamine's effects on ANP synthesis and secretion. |
Abstract
Background: Poststroke social isolation could worsen poststroke depression and dampen neurogenesis. (R,S)-ketamine has antidepressant and neuroprotective effects; however, its roles and mechanisms in social isolation–mediated depressive-like behaviors and sensorimotor recovery remain unclear.
Methods: Mice were subjected to transient middle cerebral artery occlusion, and then were pair-housed with ovariectomized female mice or were housed isolated (ISO) starting at 3 days postischemia. ISO mice received 2 weeks of (R,S)-ketamine treatment starting at 14 days postischemia. Primary ependymal epithelial cells and choroid plexus epithelial cells were cultured and treated with recombinant human atrial natriuretic peptide (ANP) protein.
Results: The poststroke social isolation model was successfully established using middle cerebral artery occlusion combined with poststroke isolation, as demonstrated by a more prominent depression-like phenotype in ISO mice compared with pair-housed mice. (R,S)-ketamine reversed ISO-mediated depressive-like behaviors and increased ANP levels in the atrium. The depression-like phenotype was negatively correlated with ANP levels in both the atrium and plasma. Atrial GLP-1 and GLP-1 receptor signaling was essential to the promoting effects of (R,S)-ketamine on the synthesis and secretion of ANP from the atrium in ISO mice. (R,S)-ketamine also increased ANP and TGF-β1 levels in the choroid plexus of ISO mice. Recombinant human ANP increased TGF-β1 levels in both the primarily cultured ependymal epithelial cells and choroid plexus epithelial cells. Furthermore, (R,S)-ketamine increased TGF-β1 levels in the ischemic hemisphere and promoted striatal neurogenesis and sensorimotor recovery via ANP in ISO mice.
Conclusions: (R,S)-ketamine alleviated poststroke ISO-mediated depressive-like behaviors and thus promoted striatal neurogenesis and sensorimotor recovery via ANP.
Comparable studies
Other preclinical and animal studies on ketamine for depression, most cited first.
Citations in the library
Cites 5
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial American Journal of Psychiatry August 28, 2013
- Mechanistic Target of Rapamycin-Independent Antidepressant Effects of (R)-Ketamine in a Social Defeat Stress Model. Biological Psychiatry 2018
- Essential role of microglial transforming growth factor-β1 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-β1 Translational Psychiatry January 27, 2020
- Ketamine for Depression, 1: Clinical Summary of Issues Related to Efficacy, Adverse Effects, and Mechanism of Action. The Journal of Clinical Psychiatry April 2017
- Ketamine as a prophylactic against stress-induced depressive-like behavior Biological Psychiatry May 4, 2015